pnb-0408 dihexa clinical trial human Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects dihexa science.bio Dihexa (PNB-0408) |
Description
Another mechanism of action of BPC-157 is blocking the inhibitory growth factor called 4-hydroxynonenal, which is a negative modulator of growth
Rogic, V
doi: 10.1002/mds.23361
10.1038/nrd2590 34 EngenK.RosenstrmU.AxelssonH.KondaV.DahllundL.OtrockaM.et al (2016)
Heres the context alongside approved drugs: Its worth noting that when CagriSemas results were first announced, some analysts had expected an even higher number, so the roughly 20% figure was viewed as strong but not the blowout some anticipated
~ AlphaMD You walk into a clinic feeling exhausted, mentally foggy, and wondering where your drive went
